JUDITH COOLEY: Open Payments
NPI 1003138678 · GARDENDALE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,150 in 108 payments from 26 companies in 2025. Trend: 2023 $174 · 2024 $158 · 2025 $2,150
Food & beverage: $2,150
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $306 |
| Novo Nordisk Inc | 12 | $202 |
| PFIZER INC. | 12 | $182 |
| ABBVIE INC. | 8 | $160 |
| Lilly USA, LLC | 7 | $135 |
| Otsuka America Pharmaceutical, Inc. | 5 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $120 |
| Axsome Therapeutics, Inc. | 5 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| Amgen Inc. | 5 | $93 |
Products named: NURTEC ODT, AIRSUPRA, REXULTI, JARDIANCE, UBRELVY, Kerendia, Wegovy, Ozempic.
Industry payments across AL — which companies pay providers there.
